Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner

Campana, 2017, Regression of liver fibrosis, Semin. Liver Dis., 37, 1, 10.1055/s-0036-1597816 Povero, 2010, Liver fibrosis: a dynamic and potentially reversible process, Histol. Histopathol., 25, 1075 Higashi, 2017, Hepatic stellate cells as key target in liver fibrosis, Adv. Drug Deliv. Rev., 121, 27, 10.1016/j.addr.2017.05.007 Hazra, 2004, PPAR gamma and hepatic stellate cells, Comp. Hepatol., 3, S7, 10.1186/1476-5926-2-S1-S7 Wang, 2011, Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats, Hepatobiliary Pancreat. Dis. Int., 10, 64, 10.1016/S1499-3872(11)60009-X Kones, 2017, n−3 polyunsaturated fatty acids and cardiovascular disease: principles, practices, pitfalls, and promises - a contemporary review, Med. Princ. Pract., 26, 497, 10.1159/000485837 Firlag, 2013, The neuroprotective effect of long-term n−3 polyunsaturated fatty acids supplementation in the cerebral cortex and hippocampus of aging rats, Folia Neuropathol., 51, 235, 10.5114/fn.2013.37708 He, 2017, Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats, Int. Immunopharmacol., 53, 56, 10.1016/j.intimp.2017.09.013 Moreira, 2007, Hepatic stellate cells and liver fibrosis, Arch. Pathol. Lab. Med., 131, 1728, 10.5858/2007-131-1728-HSCALF Gani, 2008, Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?, Cardiovasc. Diabetol., 7, 6, 10.1186/1475-2840-7-6 Chen, 2016, Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway, IUBMB Life, 68, 220, 10.1002/iub.1478 Xu, 2005, Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis, Gut, 54, 142, 10.1136/gut.2004.042127 Carpino, 2005, Stud. Liver, 37, 349 Liu, 2016, Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro, Mol. Med. Rep., 14, 3669, 10.3892/mmr.2016.5673 Biernacka, 2011, TGF-beta signaling in fibrosis, Growth Factors, 29, 196, 10.3109/08977194.2011.595714 Czochra, 2006, Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice, J. Hepatol., 45, 419, 10.1016/j.jhep.2006.04.010 Bonner, 2004, Regulation of PDGF and its receptors in fibrotic diseases, Cytokine Growth Factor Rev., 15, 255, 10.1016/j.cytogfr.2004.03.006 Davis, 1988, Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture, J. Cell. Physiol., 136, 547, 10.1002/jcp.1041360323 Kawaratani, 2013, The effect of inflammatory cytokines in alcoholic liver disease, Mediat. Inflamm., 2013, 495156, 10.1155/2013/495156 Choi, 1994, IL-6 induces hepatic inflammation and collagen synthesis in vivo, Clin. Exp. Immunol., 95, 530, 10.1111/j.1365-2249.1994.tb07031.x Zimmermann, 2011, Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis, PLoS One, 6, 10.1371/journal.pone.0021381 Lien, 2009, Toxicology and safety of DHA, Prostaglandins Leukot. Essent. Fat. Acids, 81, 125, 10.1016/j.plefa.2009.05.004 Chen, 2013, Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats, Dig. Dis. Sci., 58, 440, 10.1007/s10620-012-2489-5 Rice, 2016, Fish oils in human nutrition: history and current status, 75 Nair, 2016, A simple practice guide for dose conversion between animals and human, J. Basic Clin. Pharm., 7, 27, 10.4103/0976-0105.177703 Trauner, 2011, Nuclear receptors as new perspective for the management of liver diseases, Gastroenterology, 140, 1120, 10.1053/j.gastro.2011.02.044 Zhang, 2018, Ligand activation of PPARgamma by ligustrazine suppresses pericyte functions of hepatic stellate cells via SMRT-mediated transrepression of HIF-1alpha, Theranostics, 8, 610, 10.7150/thno.22237 Ferguson, 2018, Peroxisome proliferator activated receptor agonists modulate transposable element expression in brain and liver, Front. Mol. Neurosci., 11, 331, 10.3389/fnmol.2018.00331 Diep, 2000, Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase, Hypertension, 36, 851, 10.1161/01.HYP.36.5.851 Leesnitzer, 2002, Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662, Biochemistry, 41, 6640, 10.1021/bi0159581 Pavlov, 2009, Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel, Mol. Pharmacol., 76, 1333, 10.1124/mol.109.056911 Yan, 2010, Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling, Autophagy, 6, 67, 10.4161/auto.6.1.10437 Dong, 2011, Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway, Mol. Cell. Biochem., 358, 281, 10.1007/s11010-011-0978-z Jeon, 2014, Inhibitory effects of PPARgamma ligands on TGF-beta1-induced corneal myofibroblast transformation, Am. J. Pathol., 184, 1429, 10.1016/j.ajpath.2014.01.026 Osman, 2016, Pioglitazone, a PPARgamma agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling, Biochem. Pharmacol., 101, 54, 10.1016/j.bcp.2015.11.026 Chen, 2012, Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats, J. Nutr. Biochem., 23, 252, 10.1016/j.jnutbio.2010.11.022 Lytle, 2015, Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr−/− mice by targeting the TGFbeta-Smad3 pathway, J. Lipid Res., 56, 1936, 10.1194/jlr.M061275 Gonzalez-Periz, 2006, Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA, FASEB J., 20, 2537, 10.1096/fj.06-6250fje Zhang, 2016, Omega-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation, Sci. Rep., 6, 30029, 10.1038/srep30029 Tsuchida, 2017, Mechanisms of hepatic stellate cell activation, Nat. Rev. Gastroenterol. Hepatol., 14, 397, 10.1038/nrgastro.2017.38 Guo, 2005, Effect of ligand of peroxisome proliferator-activated receptor gamma on the biological characters of hepatic stellate cells, World J. Gastroenterol., 11, 4735, 10.3748/wjg.v11.i30.4735 Zhi, 2019, Rosiglitazone inhibits activation of hepatic stellate cells via up-regulating micro-RNA-124-3p to alleviate hepatic fibrosis, Dig. Dis. Sci., 64, 1560, 10.1007/s10620-019-5462-8 Koga, 2001, Involvement of p21(WAF1/Cip1), p27 (Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines, Hepatology, 33, 1087, 10.1053/jhep.2001.24024 Agosti, 2014, PPAR-γ agonists induce growth arrest of kit/AML1-ETO leukemia cells acting on diverse pathways, Blood, 124, 5211, 10.1182/blood.V124.21.5211.5211 Carrano, 1999, SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27, Nat. Cell Biol., 1, 193, 10.1038/12013 Morrison, 1999, Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21 (Waf1/Cip1), during adipogenesis, J. Biol. Chem., 274, 17088, 10.1074/jbc.274.24.17088 Miller, 2018, PPARgamma-mediated p21 induction in aerodigestive preneoplastic cell lines, Ann. Otol. Rhinol. Laryngol., 127, 677, 10.1177/0003489418787833 Han, 2004, Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells, Clin. Cancer Res., 10, 1911, 10.1158/1078-0432.CCR-03-0985 Jiang, 1998, PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/34184 Pascual, 2005, A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma, Nature, 437, 759, 10.1038/nature03988 Wang, 2007, Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP, Blood, 110, 4373, 10.1182/blood-2006-07-038026 Arendt, 2015, Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n−3 and n−6 polyunsaturated fatty acids, Hepatology, 61, 1565, 10.1002/hep.27695 Lopez-Vicario, 2014, Molecular interplay between Delta5/Delta6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis, Gut, 63, 344, 10.1136/gutjnl-2012-303179 Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4, 44, 10.1038/nprot.2008.211